FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma. - Merjaneh N; Lan YW; Deng Z; Donovan J; Wang G; Do J; Juan T; Xia X; Kalinichenko VV; Kalin TV (International journal of oncology, 2026)